Skip to main content

Table 2 Association between nephrometry scores and clinical outcome variables

From: Perioperative outcomes of zero ischemia radiofrequency ablation-assisted tumor enucleation for renal cell carcinoma: results of 182 patients

Nephrometry scores

No. (%)

Estimated blood loss, ml, median (IQR)

Operative time, min, median (IQR)

Hospital stay, days, median (IQR)

Change in eGFR, median (IQR)

R.E.N.A.L. score

 Low (4–6)

132

70 (50,100)

100 (90,110)

6 (5.25,8)

−4.05 (−6.88,-1.3)

 Moderate (7–9)

43

120 (75,160)

120 (100,130)

8 (6,9)

−3.7 (−5.3,−0.9)

 High (10–12)

7

210 (170,250)

150 (120,160)

10 (8,10)

-0.9 (− 3.3,1.3)

P value

 

< 0.001

< 0.001

< 0.001

0.136

PADUA score

 Low (6–7)

108

70 (50,90)

100 (90,110)

6 (5.25,8)

− 4.2 (− 6.72,-1.3)

 Moderate (8–9)

64

100 (61.25,148.75)

102.5 (90,127.5)

8 (6,9)

− 3.4 (− 6.05,-1.12)

 High (10–13)

10

190 (127.5220)

130 (103.75,156.25)

8.5 (6.5,10)

−1.25 (− 3.35,1.95)

P value

 

< 0.001

0.002

0.005

0.112

C-index score

 Low (> 2.5)

116

70 (50,100)

100 (90,113.75)

6 (5,8)

− 3.8 (− 6.72,-0.95)

 High (< 2.5)

66

102.5 (75,162.5)

102.5 (95,130)

7.5 (6,9)

− 3.75 (− 5.98,-0.9)

P value

 

< 0.001

0.005

0.006

0.921

  1. Boldface means the data is significant (P < 0.05)